AT322551B - Verfahren zur herstellung neuer 2,4,5-trisubstituierter oxazole - Google Patents
Verfahren zur herstellung neuer 2,4,5-trisubstituierter oxazoleInfo
- Publication number
- AT322551B AT322551B AT3673A AT3673A AT322551B AT 322551 B AT322551 B AT 322551B AT 3673 A AT3673 A AT 3673A AT 3673 A AT3673 A AT 3673A AT 322551 B AT322551 B AT 322551B
- Authority
- AT
- Austria
- Prior art keywords
- preparing new
- oxazoles
- trisubstituted
- trisubstituted oxazoles
- preparing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2795872 | 1972-08-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
AT322551B true AT322551B (de) | 1975-05-26 |
Family
ID=11222675
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT3673A AT322551B (de) | 1972-08-07 | 1973-01-02 | Verfahren zur herstellung neuer 2,4,5-trisubstituierter oxazole |
Country Status (23)
Country | Link |
---|---|
JP (1) | JPS5030619B2 (ko) |
KR (1) | KR780000069B1 (ko) |
AR (1) | AR200007A1 (ko) |
AT (1) | AT322551B (ko) |
AU (1) | AU477231B2 (ko) |
BE (1) | BE794096A (ko) |
CH (1) | CH544105A (ko) |
CS (1) | CS177127B2 (ko) |
DD (1) | DD106387A5 (ko) |
DE (1) | DE2301030A1 (ko) |
ES (1) | ES417638A1 (ko) |
FR (1) | FR2195430B1 (ko) |
GB (1) | GB1374345A (ko) |
HU (1) | HU164781B (ko) |
IE (1) | IE36941B1 (ko) |
IL (1) | IL40904A (ko) |
LU (1) | LU66643A1 (ko) |
NL (1) | NL149797B (ko) |
NO (1) | NO137550C (ko) |
RO (1) | RO63442A (ko) |
SE (1) | SE376236B (ko) |
SU (1) | SU511003A3 (ko) |
ZA (1) | ZA728259B (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0167973A1 (de) * | 1984-07-07 | 1986-01-15 | Roche Diagnostics GmbH | Redox-Indikatoren |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DD112905A5 (ko) * | 1971-09-02 | 1975-05-12 | Snam Progetti | |
US4110256A (en) * | 1976-06-22 | 1978-08-29 | Nippon Soken, Inc. | Catalyst for reforming fuel and method for producing same |
JPS59125900U (ja) * | 1983-02-10 | 1984-08-24 | マルヤス機械株式会社 | 組立ライン装置 |
JPS6133499U (ja) * | 1984-07-30 | 1986-02-28 | 中西金属工業株式会社 | 電気製品製造用パレツト |
ES2245660T3 (es) * | 1990-11-30 | 2006-01-16 | Otsuka Pharmaceutical Co., Ltd. | Derivados de azol y su utilizacion como inhibidores de los radicales superoxidos. |
GB0709031D0 (en) | 2007-05-10 | 2007-06-20 | Sareum Ltd | Pharmaceutical compounds |
WO2010111059A1 (en) | 2009-03-23 | 2010-09-30 | Merck Sharp & Dohme Corp. | P2x3 receptor antagonists for treatment of pain |
GB201202027D0 (en) | 2012-02-06 | 2012-03-21 | Sareum Ltd | Pharmaceutical compounds |
US20130231340A1 (en) | 2012-03-02 | 2013-09-05 | Sareum Limited | Pharmaceutical compounds |
GB201617871D0 (en) | 2016-10-21 | 2016-12-07 | Sareum Limited | Pharmaceutical compounds |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1226548A (ko) * | 1967-06-14 | 1971-03-31 | Wyeth John & Brother Ltd |
-
0
- BE BE794096D patent/BE794096A/xx unknown
-
1972
- 1972-05-29 RO RO7200074945A patent/RO63442A/ro unknown
- 1972-11-09 NO NO4068/72A patent/NO137550C/no unknown
- 1972-11-14 SE SE7214772A patent/SE376236B/xx unknown
- 1972-11-22 IL IL40904A patent/IL40904A/xx unknown
- 1972-11-22 ZA ZA728259A patent/ZA728259B/xx unknown
- 1972-11-27 CH CH1723972A patent/CH544105A/fr not_active IP Right Cessation
- 1972-12-04 IE IE1677/72A patent/IE36941B1/xx unknown
- 1972-12-13 LU LU66643A patent/LU66643A1/xx unknown
- 1972-12-14 GB GB5396672A patent/GB1374345A/en not_active Expired
- 1972-12-29 HU HULE673A patent/HU164781B/hu unknown
-
1973
- 1973-01-02 AT AT3673A patent/AT322551B/de not_active IP Right Cessation
- 1973-01-10 DE DE2301030A patent/DE2301030A1/de active Pending
- 1973-01-10 NL NL737300326A patent/NL149797B/xx unknown
- 1973-01-18 AR AR246173A patent/AR200007A1/es active
- 1973-01-19 FR FR7301948A patent/FR2195430B1/fr not_active Expired
- 1973-01-25 JP JP48010642A patent/JPS5030619B2/ja not_active Expired
- 1973-04-16 CS CS2724A patent/CS177127B2/cs unknown
- 1973-06-15 AU AU56982/73A patent/AU477231B2/en not_active Expired
- 1973-07-20 DD DD172403A patent/DD106387A5/xx unknown
- 1973-08-06 SU SU1942243A patent/SU511003A3/ru active
- 1973-08-07 ES ES417638A patent/ES417638A1/es not_active Expired
- 1973-08-07 KR KR7301283A patent/KR780000069B1/ko active
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0167973A1 (de) * | 1984-07-07 | 1986-01-15 | Roche Diagnostics GmbH | Redox-Indikatoren |
Also Published As
Publication number | Publication date |
---|---|
HU164781B (ko) | 1974-04-11 |
NL7300326A (ko) | 1974-02-11 |
CH544105A (fr) | 1973-11-15 |
BE794096A (fr) | 1973-05-16 |
AU5698273A (en) | 1974-12-19 |
KR780000069B1 (en) | 1978-03-30 |
IE36941B1 (en) | 1977-03-30 |
JPS4945067A (ko) | 1974-04-27 |
AU477231B2 (en) | 1976-10-21 |
NO137550C (no) | 1978-03-15 |
AR200007A1 (es) | 1974-10-15 |
ES417638A1 (es) | 1976-02-01 |
FR2195430A1 (ko) | 1974-03-08 |
DD106387A5 (ko) | 1974-06-12 |
NO137550B (no) | 1977-12-05 |
FR2195430B1 (ko) | 1976-04-09 |
CS177127B2 (ko) | 1977-07-29 |
SE376236B (ko) | 1975-05-12 |
DE2301030A1 (de) | 1974-02-28 |
JPS5030619B2 (ko) | 1975-10-02 |
NL149797B (nl) | 1976-06-15 |
SU511003A3 (ru) | 1976-04-15 |
RO63442A (fr) | 1978-07-15 |
GB1374345A (en) | 1974-11-20 |
IL40904A0 (en) | 1973-01-30 |
IL40904A (en) | 1975-12-31 |
ZA728259B (en) | 1973-07-25 |
IE36941L (en) | 1974-02-07 |
LU66643A1 (ko) | 1973-02-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AT333752B (de) | Verfahren zur herstellung neuer benzoxazol-derivate | |
AT329561B (de) | Verfahren zur herstellung neuer 1,4-dihydropyridine | |
CH542232A (de) | Verfahren zur Herstellung neuer 1,2,4-Oxadiazol-Derivate | |
DD110652A5 (de) | Verfahren zur herstellung neuer 1-aryloxy-2-hydroxy-3-alkinylaminopropane | |
AT333987B (de) | Verfahren zur herstellung neuer insulinderivate | |
AT322551B (de) | Verfahren zur herstellung neuer 2,4,5-trisubstituierter oxazole | |
ATA1000074A (de) | Verfahren zur herstellung von neuen oxazolderivaten | |
CH549596A (de) | Verfahren zur herstellung neuer n(6)-aralkyl-adenosinderivate. | |
CH556351A (de) | Verfahren zur herstellung neuer trisubstituierter oxazole. | |
AT324309B (de) | Verfahren zur herstellung neuer 2-aminoalkanoylaminobenzophenone | |
CH555798A (de) | Verfahren zur herstellung neuer 1,1-diphenyl-2-nitropropanderivate. | |
AT329041B (de) | Verfahren zur herstellung neuer 2-(n-phenyl-n- (r1,r2-aminoalkyl) )-amino- (1,2,3,4-tetrahydronaphthaline) | |
CH556835A (de) | Verfahren zur herstellung neuer spiroindanpyrrolidinderivate. | |
CH520156A (de) | Verfahren zur Herstellung neuer Perhydro-5-phenylcyclo-alkapolyen-1,4-oxazepine | |
AT326120B (de) | Verfahren zur herstellung neuer isoxazolidinderivate | |
AT332001B (de) | Verfahren zur herstellung der neuen 20beta-hydroxy-9-oxo- 1,2,3,4,10,19 -hexanor-5,9-seco-pregnan-5-saure | |
AT336603B (de) | Verfahren zur herstellung neuer oxazolidine | |
ATA606775A (de) | Verfahren zur herstellung neuer substituierter chloracetanilide | |
ATA304175A (de) | Verfahren zur herstellung neuer benzoxazol-derivate | |
ATA304275A (de) | Verfahren zur herstellung neuer benzoxazol-derivate | |
ATA177175A (de) | Verfahren zur herstellung neuer 1,4-dihydropyridine | |
CH546240A (de) | Verfahren zur herstellung neuer indenopyridinderivate. | |
AT332417B (de) | Verfahren zur herstellung neuer 1,2,4- benztriazin -1,4-di-n- oxidderivate | |
AT325595B (de) | Verfahren zur herstellung des neuen 1,3,3-trimethyl-1-octylaminomethyl-5-octylamino-cyclohexans | |
ATA328274A (de) | Verfahren zur herstellung neuer substituierter chloracetanilide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ELJ | Ceased due to non-payment of the annual fee |